Literature DB >> 14770284

[Differential congenital myasthenia syndrome diagnosis].

S Spuler1, T-N Lehmann, A G Engel.   

Abstract

Among myopathies and disorders of neuromuscular transmission, the congenital myasthenic syndromes (CMS) are particularly rare. However, because of the available therapeutic options, it is still clinically important to achieve a correct diagnosis in these patients. We report an adult patient with ophthalmoplegia and nonfluctuating limb-girdle syndrome. For almost 20 years, a congenital myopathy or mitochondriopathy had been suspected before CMS was diagnosed caused by an epsilon subunit mutation of the acetylcholine receptor (epsilon1276delG).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770284     DOI: 10.1007/s00115-003-1614-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

1.  Treatment of slow-channel congenital myasthenic syndrome with fluoxetine.

Authors:  C Michel Harper; Takayasu Fukodome; Andrew G Engel
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

Review 2.  Sleuthing molecular targets for neurological diseases at the neuromuscular junction.

Authors:  Andrew G Engel; Kinji Ohno; Steven M Sine
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

3.  Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.

Authors:  C M Harper; A G Engel
Journal:  Ann Neurol       Date:  1998-04       Impact factor: 10.422

4.  A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome.

Authors:  Angela Abicht; Rolf Stucka; Carolin Schmidt; Alexandre Briguet; Sebastian Höpfner; In-Ho Song; Dieter Pongratz; Wolfgang Müller-Felber; Markus A Ruegg; Hanns Lochmüller
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

5.  Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor.

Authors:  K Ohno; B Anlar; E Ozdirim; J M Brengman; J L DeBleecker; A G Engel
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

Review 6.  Congenital myasthenic syndromes: progress over the past decade.

Authors:  Andrew G Engel; Kinji Ohno; Steven M Sine
Journal:  Muscle Nerve       Date:  2003-01       Impact factor: 3.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.